Prot#17-546: NU DF18C03 - A Phase II Study of Atezolizumab in Combination with Pertuzumab Plus High-Dose Trastuzumab for the Treatment of Central Nervous System Metastases in Patients with Her2-Positive Breast Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date3/26/193/26/22

Funding

  • Dana-Farber Cancer Institute (Prot#17-546)
  • Genentech, Inc. (Prot#17-546)